Clinical trial Recruiting at 1 site Interventional Ages 22 and up

Crosslinked hyaluronate gel to help dry eye during cataract surgery

Official title: A Prospective, Single-Arm Study Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of Dry Eye Disease in Patients Undergoing Refractive Cataract Surgery

Run by Vance Thompson Vision · NCT07155057 · Data updated 2026-11-12

This tests whether putting a crosslinked hyaluronate canalicular gel to block the tear ducts before cataract surgery helps people with dry eye disease who are getting advanced intraocular lenses.

Quick facts

Study typeInterventional
Ages22 Years and up
SexAll
Enrollment60 (estimated)
SponsorVance Thompson Vision
Academic / other
Locations1 site (Sioux Falls, South Dakota)
StatusRecruiting
StartedSeptember 3, 2025
Main results expectedJune 2026
Study endsDecember 2026
Registry record updatedSeptember 29, 2025
Trial IDNCT07155057 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (22 or older) with diagnosed dry eye disease (OSDI ≥13 and tear break-up time ≤10 seconds in at least one eye) who are electing advanced technology lens implants and can attend study visits.

Probably not a fit

Patients with prior punctal cautery, obstructive lacrimal anatomy, or who are not receiving advanced IOLs (or cannot travel to the study site) may not receive benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-site, single-arm study enrolling 60 patients with dry eye disease who have chosen advanced intraocular lens implantation at the time of cataract surgery. Participants will receive bilateral lacrimal occlusion with a crosslinked hyaluronate canalicular gel placed preoperatively. The study includes five visits over a 3–5 month period to capture patient-reported use and outcomes. Data will focus on symptom reporting and tolerability around the surgical period.

Why it matters

Potential benefit: If successful, this approach could reduce dry eye symptoms around cataract surgery and improve comfort and visual outcomes after advanced IOL implantation.

How similar studies have gone: Punctal occlusion is an established treatment for dry eye, but using a crosslinked hyaluronate canalicular gel is a newer, less-studied method compared with traditional plugs or cautery.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Be willing and able to understand and sign the informed consent form (ICF)
* Men or non-pregnant women age 22 or older
* Clear intraocular media other than cataract
* Diagnosis of dry eye disease (OSDI score ≥ 13)
* Non-invasive Tear break up time ≤ 10 seconds in at least one eye
* Willing and able to comply with all study related visits and procedures
* In the opinion of the investigator, patients who are appropriate for advanced technology lens implants

Exclusion Criteria:

* History of punctal cautery
* Lacrimal anatomy (e.g., nasolacrimal duct obstruction) that per investigator suggests that the patient would not be a good candidate for lacrimal occlusion or patients for whom lacrimal occlusion would increase risk

Where it's running

  • Vance Thompson Vision Clinic, Prof. LLC
    Sioux Falls, South Dakota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.